麒麟集團(08109.HK)折讓9.1%配售最多3,000萬股 料淨籌870萬元
麒麟集團控股(08109.HK)公布,透過配售代理按盡力基準以每股配售股份0.3元之價格向不少於六名承配人配售最多3,000萬股配售股份。配售價較股份於最後交易日在聯交所所報收市價每股0.33元折讓約9.1%;及協議日期前之最後五個連續交易日平均收市價每股0.308元折讓約2.6%。
配售股份的最大數目相當於公司於現有已發行股本約12.67%;及經配發及發行配售股份擴大之已發行股本約11.24%。
假設根據配售協議配售最大數目的配售股份,配售所得款項總額將約900萬元,而所得款項淨額將約870萬元,即淨發行價約為每股配售股份0.29元。集團擬將所得款項淨額用於償還未償還債務約700萬元;及其餘所得款項將用作集團的一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.